Efficacy and safety of HLA-B7/beta-2 microglobulin plasmid DNA/lipid complex (Allovectin-7) in patients with metastatic melanoma.
about
Advancement and prospects of tumor gene therapyPhase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanomaImmunotherapy for melanoma: current status and perspectives.Engineering nanomedicines for improved melanoma therapy: progress and promises.Phospholipid-based artificial viruses assembled by multivalent cations.
P2860
Efficacy and safety of HLA-B7/beta-2 microglobulin plasmid DNA/lipid complex (Allovectin-7) in patients with metastatic melanoma.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Efficacy and safety of HLA-B7/ ...... ents with metastatic melanoma.
@ast
Efficacy and safety of HLA-B7/ ...... ents with metastatic melanoma.
@en
type
label
Efficacy and safety of HLA-B7/ ...... ents with metastatic melanoma.
@ast
Efficacy and safety of HLA-B7/ ...... ents with metastatic melanoma.
@en
prefLabel
Efficacy and safety of HLA-B7/ ...... ents with metastatic melanoma.
@ast
Efficacy and safety of HLA-B7/ ...... ents with metastatic melanoma.
@en
P2093
P2860
P356
P1476
Efficacy and safety of HLA-B7/ ...... ents with metastatic melanoma.
@en
P2093
Michael Bergen
Rene Gonzalez
Robert Chen
P2860
P304
P356
10.1517/14712598.3.2.377
P407
P577
2003-04-01T00:00:00Z